CLINICAL_TRIALS
trial_result
· 2011-04-26
Clinical Trial Update: The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease [Phase 2]
Summary
Phase 2 trial update assessing safety and effectiveness of AA4500 in Peyronie's disease; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Endo Pharmaceuticals | Conditions: Peyronie's Disease | Phase 2 | Status: COMPLETED | Results posted: 2011-04-26